{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:49:12Z","timestamp":1790124552936,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":620,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1038\/s41379-020-00729-y","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T09:09:04Z","timestamp":1611306544000},"page":"1017-1030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status"],"prefix":"10.1016","volume":"34","author":[{"given":"Xiaoqin","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Jamshed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azniv","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venu","family":"Bathini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8599-4352","authenticated-orcid":false,"given":"Karen","family":"Dresser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Strock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargavi","family":"Yalamarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Tomaszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tjionas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7306-8813","authenticated-orcid":false,"given":"Mark C.","family":"Mochel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2387-5462","authenticated-orcid":false,"given":"Jacob R.","family":"Bledsoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-00729-y_bib1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/s41379-020-00729-y_bib2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.15585\/mmwr.mm6733a2","article-title":"Trends in human papillomavirus-associated cancers\u2014United States, 1999-2015","volume":"67","author":"Van Dyne","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1038\/s41379-020-00729-y_bib3","doi-asserted-by":"crossref","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines","volume":"107","author":"Saraiya","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-020-00729-y_bib4","doi-asserted-by":"crossref","unstructured":"Yalamarti B, George, M, Hutchinson L, Cosar E, Maranda L, Switzer BA, et al. Tumor HPV status and invasive squamous cell carcinoma of the anus: outcomes from a single institution. J Clin Oncol 2014;32:5s (Suppl; abstr 4035).","DOI":"10.1200\/jco.2014.32.15_suppl.4035"},{"key":"10.1038\/s41379-020-00729-y_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clon.2019.06.013","article-title":"A systematic review and meta-analysis of prognostic biomarkers in anal squamous cell carcinoma treated with primary chemoradiotherapy","volume":"31","author":"Parwaiz","year":"2019","journal-title":"Clin Oncol (R Coll Radio)"},{"key":"10.1038\/s41379-020-00729-y_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PAS.0000000000000594","article-title":"Basaloid squamous cell carcinoma of the anus revisited","volume":"40","author":"Graham","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib7","doi-asserted-by":"crossref","first-page":"8081","DOI":"10.18632\/oncotarget.23545","article-title":"The prognostic value of HPV combined p16 status in patients with anal squamous cell carcinoma: a meta-analysis","volume":"9","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-020-00729-y_bib8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.21037\/tcr.2017.06.13","article-title":"Human papillomavirus related anal squamous cell carcinoma survival: a systematic review and meta-analysis","volume":"6","author":"Yao","year":"2017","journal-title":"Transl Cancer Res"},{"key":"10.1038\/s41379-020-00729-y_bib9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12876-018-0758-2","article-title":"HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma","volume":"18","author":"Soares","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"10.1038\/s41379-020-00729-y_bib10","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/1541-7786.MCR-17-0060","article-title":"Comprehensive genomic profiling of metastatic squamous cell carcinoma of the anal canal","volume":"15","author":"Morris","year":"2017","journal-title":"Mol Cancer Res"},{"key":"10.1038\/s41379-020-00729-y_bib11","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/annonc\/mdw152","article-title":"Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes","volume":"27","author":"Chung","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-020-00729-y_bib12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.18632\/oncotarget.23066","article-title":"Exome sequencing reveals aberrant signalling pathways as hallmark of treatment-naive anal squamous cell carcinoma","volume":"9","author":"Cacheux","year":"2018","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-020-00729-y_bib13","doi-asserted-by":"crossref","first-page":"43594","DOI":"10.18632\/oncotarget.6202","article-title":"Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas","volume":"6","author":"Smaglo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-020-00729-y_bib14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/bjc.2016.144","article-title":"Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection","volume":"114","author":"Cacheux","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-00729-y_bib15","doi-asserted-by":"crossref","unstructured":"Bruyere D, Monnien F, Colpart P, Roncarati P, Vuitton L. Treatment algorithm and prognostic factors for patients with stage I-III carcinoma of the anal canal: a 20-year multicenter study. Mod Pathol. 2020. https:\/\/doi.org\/10.1038\/s41379-020-0637-6. Online ahead of print.","DOI":"10.1038\/s41379-020-0637-6"},{"key":"10.1038\/s41379-020-00729-y_bib16","first-page":"6489","article-title":"Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma","volume":"9","author":"Allal","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-00729-y_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0360-3016(99)00188-1","article-title":"Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal","volume":"45","author":"Wong","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1038\/s41379-020-00729-y_bib18","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/bjc.2015.20","article-title":"HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53","volume":"112","author":"Meulendijks","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-00729-y_bib19","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.bjc.6605984","article-title":"Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review","volume":"103","author":"Lampejo","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-00729-y_bib20","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1226::AID-CNCR3>3.0.CO;2-B","article-title":"Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04","volume":"85","author":"Bonin","year":"1999","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-00729-y_bib21","doi-asserted-by":"crossref","first-page":"11451","DOI":"10.1128\/JVI.78.21.11451-11460.2004","article-title":"Mechanisms of human papillomavirus-induced oncogenesis","volume":"78","author":"Munger","year":"2004","journal-title":"J Virol"},{"key":"10.1038\/s41379-020-00729-y_bib22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/PAS.0000000000000809","article-title":"Human papillomavirus genotypic of incidental malignant and premalignant lesions on hemorrhoidectomy specimens","volume":"41","author":"Hui","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.radonc.2013.08.002","article-title":"p16INK4a, p53, EGFR expression and KRAS mutation in squamous cell cancers of the anus: correlation with outcomes following chemo-radiotherapy","volume":"109","author":"Gilbert","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1038\/s41379-020-00729-y_bib24","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/01.MP.0000077417.08371.CE","article-title":"Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA","volume":"16","author":"Lu","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib25","doi-asserted-by":"crossref","unstructured":"Marabelle A, Cassier PA, Fakih M, Guren TK, Italiano A, Kao SC-H, et al. Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): results from the multicohort, phase II KEYNOTE-158 study. J Clin Oncol. 2020;38 (Suppl 4: abstract 1;1-1) https:\/\/doi.org\/10.1200\/JCO.2020.38.4_suppl.1.","DOI":"10.1200\/JCO.2020.38.4_suppl.1"},{"key":"10.1038\/s41379-020-00729-y_bib26","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/annonc\/mdx029","article-title":"Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal","volume":"28","author":"Ott","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-020-00729-y_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1470-2045(17)30104-3","article-title":"Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study","volume":"18","author":"Morris","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1038\/s41379-020-00729-y_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/his.12955","article-title":"Mutually exclusive extracellular signal-regulated kinase pathway mutations are present in different stages of multi-focal pulmonary Langerhans cell histiocytosis supporting clonal nature of the disease","volume":"69","author":"Kamionek","year":"2016","journal-title":"Histopathology"},{"key":"10.1038\/s41379-020-00729-y_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00428-016-1965-2","article-title":"Somatic mutations in histiocytic sarcoma identified by next generation sequencing","volume":"469","author":"Liu","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-020-00729-y_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.humpath.2018.11.011","article-title":"Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms","volume":"85","author":"Zhu","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib31","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1309\/AJCPCQD7B7DPVHLH","article-title":"Cervista HR and HPV 16\/18 assays versus hybrid capture 2 assay: outcome comparison in women with negative cervical cytology","volume":"136","author":"Kurian","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib32","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.5858\/arpa.2013-0354-AB","volume":"137","author":"Moghaddam","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-020-00729-y_bib33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/JCM.02007-08","article-title":"Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus","volume":"47","author":"Soderlund-Strand","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1038\/s41379-020-00729-y_bib34","unstructured":"Meng X, Amini N, Dresser K, Deng A, Hutchinson L. Molecular analysis for HPV may aid in the diagnosis of ambiguous anogenital condylomas. American Society of Dermatopathology (ASDP) 2019 Annual Meeting October 17\u201320, 2019. Poster session 1\u2013 #128."},{"key":"10.1038\/s41379-020-00729-y_bib35","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/modpathol.3800960","article-title":"Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations","volume":"20","author":"Li","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib36","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/modpathol.2011.85","article-title":"Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis","volume":"24","author":"Yemelyanova","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib37","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1097\/01.pas.0000172193.32918.92","article-title":"Basaloid squamous carcinoma of the anal canal with an adenoid cystic pattern: histologic and immunohistochemical reappraisal of an unusual variant","volume":"29","author":"Chetty","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib38","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1158\/1078-0432.CCR-16-2017","article-title":"Genomic evolution after chemoradiotherapy in anal squamous cell carcinoma","volume":"23","author":"Mouw","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-00729-y_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/CMR.00013-15","article-title":"Human papillomavirus laboratory testing: the changing paradigm","volume":"29","author":"Burd","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1038\/s41379-020-00729-y_bib40","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/PAS.0000000000001247","article-title":"Clinicopathologic features of anal and perianal squamous cell carcinomas and their relationship to human papillomavirus","volume":"43","author":"Ju","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/PAS.0000000000000800","article-title":"HR-HPV E6\/E7 mRNA in situ hybridization: validation against PCR, DNA in situ hybridization, and p16 immunohistochemistry in 102 samples of cervical, vulvar, anal, and head and neck neoplasia","volume":"41","author":"Mills","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib42","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/modpathol.2013.75","article-title":"Clinicopathologic analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma","volume":"26","author":"Patil","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib43","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41379-020-0524-1","article-title":"Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status","volume":"33","author":"Basile","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib44","doi-asserted-by":"crossref","first-page":"998","DOI":"10.21037\/jgo.2017.10.05","article-title":"Prognostic relevance of human papillomavirus infection in anal squamous cell carcinoma: analysis of the national cancer data base","volume":"8","author":"Jhaveri","year":"2017","journal-title":"J Gastrointest Oncol"},{"key":"10.1038\/s41379-020-00729-y_bib45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ijrobp.2015.08.004","article-title":"Prognostic relevance of HPV infection and p16 overexpression in squamous cell anal cancer","volume":"93","author":"Mai","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1038\/s41379-020-00729-y_bib46","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.2015-0091","article-title":"Clinicopathologic features associated with human papillomavirus\/p16 in patients with metastatic squamous cell carcinoma of the anal canal","volume":"20","author":"Morris","year":"2015","journal-title":"Oncologist"},{"key":"10.1038\/s41379-020-00729-y_bib47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/path.2784","article-title":"The role of mutant p53 in human cancer","volume":"223","author":"Goh","year":"2011","journal-title":"J Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib48","doi-asserted-by":"crossref","unstructured":"Willis O, Choucair K, Alloghbi A, Stanbery L, Mowat R, Brunicardi FC, et al. PIK3CA gene aberrancy and role in targeted therapy of solid malignancies. Cancer Gene Ther. 2020.","DOI":"10.1038\/s41417-020-0164-0"},{"key":"10.1038\/s41379-020-00729-y_bib49","doi-asserted-by":"crossref","first-page":"11168","DOI":"10.18632\/oncotarget.2584","article-title":"Targeted PI3K\/AKT\/mTOR therapy of metastatic carcinomas of the cervix: a phase I clinical experience","volume":"5","author":"Hou","year":"2014","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-020-00729-y_bib50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.celrep.2013.12.035","article-title":"Assessing PIK3CA and PTEN in early-phase trials with PI3K\/AKT\/mTOR inhibitors","volume":"6","author":"Janku","year":"2014","journal-title":"Cell Rep"},{"key":"10.1038\/s41379-020-00729-y_bib51","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1158\/1078-0432.CCR-15-2225","article-title":"Phase I study of apitolisib (GDC-0980), dual phosphatidlyinositol-3-kinase and mammalian target of rapamycin kinase inhibitor, in patients with advanced solid tumors","volume":"22","author":"Dolly","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-00729-y_bib52","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.humpath.2014.08.001","article-title":"No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status","volume":"45","author":"Prigge","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib53","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000259615","article-title":"Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status","volume":"77","author":"Lukan","year":"2009","journal-title":"Oncology"},{"key":"10.1038\/s41379-020-00729-y_bib54","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10495-009-0330-1","article-title":"Targeting p53 for enhanced radio- and chemo- sensitivity","volume":"14","author":"Lu","year":"2009","journal-title":"Apoptosis"},{"key":"10.1038\/s41379-020-00729-y_bib55","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/1078-0432.CCR-11-2260","article-title":"TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence","volume":"18","author":"Skinner","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"Pt B","key":"10.1038\/s41379-020-00729-y_bib56","first-page":"1","article-title":"Biologic agents. Volume 100 B. A review of human carcinogens","volume":"100","author":"IARC working group on the evaluation of carcinogenic risks to humans.","year":"2012","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"10.1038\/s41379-020-00729-y_bib57","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1038\/s41379-020-00729-y_bib58","first-page":"98","article-title":"Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide","volume":"136","author":"Alemany","year":"2015","journal-title":"J Cancer"},{"key":"10.1038\/s41379-020-00729-y_bib59","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/s41379-020-0584-2","article-title":"CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma","volume":"33","author":"Williams","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-020-00729-y_bib60","unstructured":"Graham R. Anal squamous cell carcinoma. In: Goldblum J, Klimstra D, Lam A, editors. Digestive system tumours. WHO classification of Tumours. 5th ed. Lyon, France: International Agency for Reseach on Cancer; 2019. p. 205\u2013107."}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-00729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-00729-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222006299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222006299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-020-00729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:38:01Z","timestamp":1760229481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222006299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0893395222006299"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-00729-y","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739415552.793583880","asserted-by":"object"}]},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-00729-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}